New relapse prediction tool reduces cost of rheumatoid arthritis treatment
Saturday, June 17, 2017 - 16:22
in Health & Medicine
The combined use of two measurements to accurately predict the risk of relapse in patients with rheumatoid arthritis (RA) allows successful dose reduction (tapering) of their disease modifying anti-rheumatic drugs (DMARDs), research shows. This in turn increases the cost-effectiveness of each DMARD treatment.